Results 121 to 130 of about 3,152,690 (357)
Medications, epilepsy and climate change: Added layers of complexity
Climate change—the global crisis with pervasive health impacts—has adverse consequences for people with epilepsy (PWE) who have low quality of life due to poor seizure control, socioeconomic disadvantages and comorbidities. This review focuses on the potential effects of climate change on the pharmacological characteristics of antiseizure medications ...
Medine I. Gulcebi+2 more
wiley +1 more source
Metabolic syndrome and cerebrovascular disorders
A combination of a number of risk factors, known as metabolic syndrome (MS), leads to fast progression of vascular diseases and the development of severe complications.
M. M. Tanashyan+5 more
doaj +1 more source
Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease [PDF]
Background: Insulin-like growth factor (IGF)-1 has been implicated in the pathogenesis of Alzheimer's disease ( AD). Methods: We compared the level of circulating total and bioavailable IGF-1, by simultaneous measurements of IGF-1 and IGF binding ...
Bowie, P.C.W+5 more
core +1 more source
Aims We sought to characterize adverse events and deaths associated with the use of psychoactive substances in children and adolescents. Methods Two French Addictovigilance databases were analysed: spontaneous reports and deaths over the period 2016–2021, in subjects aged 10–<18 years. An unsupervised classification was implemented on consumption data (
Hélène Peyrière+13 more
wiley +1 more source
Aims In 2013, risk minimization measures (RMMs) were introduced in Europe to address the increased cardiovascular risk linked to diclofenac. This study aimed to assess the impact of those RMMs on analgesic use. Methods Primary care data from CPRD GOLD (UK) were used.
Tomas Lasys+5 more
wiley +1 more source
CEREBROVASCULAR MORBIDITY, LETHALITY AND MORTALITY IN THE MOSCOW REGION IN 2014
Background: Cerebrovascular disorders are major contributors into mortality of the population. Annually, more than 14 000 subjects die of cardiovascular disorders in the Moscow Region, 50% of them when being in a hospital.Aim: Informational support of ...
A. N. Gurov, N. A. Katuntseva
doaj +1 more source
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. [PDF]
Apolipoprotein (apo) E was initially described as a lipid transport protein and major ligand for low density lipoprotein (LDL) receptors with a role in cholesterol metabolism and cardiovascular disease.
Mahley, Robert W
core +1 more source
ABSTRACT Cariniana rubra, native to the Brazilian Cerrado and the Amazon‐Cerrado ecotone, is traditionally used in folk medicine but remains underexplored. This study optimized extraction yield and bioactive compound content using ultrasound‐assisted extraction (UAE) and Soxhlet extraction.
Aline Biggi Maciel+5 more
wiley +1 more source
Introduction: Although cerebral edema is common following traumatic brain injury (TBI), its formation and progression are poorly understood. This is especially true for the mild TBI population, who rarely undergo magnetic resonance imaging (MRI) studies,
Jacquie Lee+8 more
doaj
Morphogenetic Variability as Potential Biomarker of Functional Outcome After Ischemic Stroke
The aim of our study was to evaluate the role of morphogenetic variability in functional outcome of patients with ischemic stroke. The prospective study included 140 patients with acute ischemic stroke, all of whom were tested upon: admission; discharge;
Milan Savic+6 more
doaj +1 more source